Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
Software integration improves bioprocess development
Biomarkers : 02 March, 2015
The ambr systems from SSB are now integrated with Design of Experiments software for use by bioprocess scientists to improve development activities
Buffer screening instrument improves university research
Biomarkers : 18 March, 2014
Students at Manchester University are being encouraged to introduce buffer screening in their biomolecular analysis projects
New data highlighting potential for monthly drug dosing
Biomarkers : 29 January, 2014
Data set presented at PepTalk 2014 demonstrate technological advances for extending serum half-life of drugs bound to albumin
Biomarker is identified in the 2013 ACC/AHA Guidelines for the Management of Heart Failure
Biomarkers : 12 June, 2013
The American College of Cardiology Foundation/American Heart Association Task Force jointly released the organizations's expanded clinical practice guideline for the management of patients with heart failure and has identified Critical Diagnostics' biomarker ST2 "not only predictive of hospitalization and death in patients with HF [heart failure] but also additive to natriuretic peptide levels in [its] prognostic value."
Qiagen expands biomarker pipeline of personalized healthcare companion diagnostics
Biomarkers : 03 June, 2013
Qiagen signs two agreements which adds new biomarkers involving glioblastoma, lymphoma and other cancers to Qiagen's expanding portfolio of potential companion diagnostics that is being developed to help doctors use a patient's genomic information to guide treatment decisions.
Study shows point-of-care biomarker improves diagnosis of AKI in the emergency department
Biomarkers : 08 March, 2013
Alere is reporting results of a study published in Critical Care that demonstrates that plasma neutrophil gelatinase-associated lipocalin (pNGAL), a biomarker that aids in the early detection of acute kidney injury (AKI), improved the diagnosis of AKI when added to clinical judgement.
RayBiotech agrees neuroscience biomarker agreement with Banner Sun Health Research Institute
Biomarkers : 04 February, 2013
RayBiotech executes a master services agreement with Banner Sun Health Research Institute (BSHRI) of Sun City, Arizona, USA.
Novel cardiac biomarker helps predict progression of heart failure in chronic HIV-infected patients
Biomarkers : 13 November, 2012
A presentation at the American Heart Association Scientific Sessions in Los Angeles, California, USA reveals the results of a study that demonstrated elevated levels of the biomarker ST2 in HIV patients was strongly indicative of the development of heart failure and mortality.
Consortium receives funding to research Sepsis biomarkers
Biomarkers : 12 November, 2012
A consortium involving the University of Brighton is awarded about £400,000 for research into a diagnostic aid to combat one of the UK's biggest killers.
EKF signs exclusive licensing deal for novel kidney markers
Biomarkers : 23 July, 2012
EKF Diagnostics Holdings signs an exclusive license agreement with the Joslin Diabetes Center, a teaching, research and clinical care affiliate of Harvard Medical School, to license certain novel kidney biomarker technology.
Affymetrix collaborates with MGH to develop new oncology biomarkers
Biomarkers : 07 June, 2012
Affymetrix is making a research collaboration and licensing agreement with Massachusetts General Hospital (MGH) to co-develop new cancer biomarker tests using the Affymetrix' QuantiGene ViewRNA Assay platform, an in situ hybridization assay capable of single transcript in single-cell detection.
Almac signs global distribution deal with Affymetrix
Biomarkers : 30 March, 2012
Almac signs an exclusive global distribution deal with Affymetrix enabling the company to directly sell Almac's proprietary Xcel array for biomarker discovery, development and delivery worldwide.
Sirius Genomics enlist eight centres for biomarker search
Biomarkers : 13 October, 2011
Sirius Genomics is launching a large, international study that enlists the help of some of the world's top acute care centres in a hunt for a biomarker that would predict outcome from a controversial treatment using activated protein C.
Qiagen partners Eli Lilly to develop molecular companion diagnostic
Biomarkers : 07 September, 2011
Qiagen is entering into a partnership with Eli Lilly for the development, manufacturing and commercialization of a molecular companion diagnostic for an early stage investigational compound currently being developed by Lilly.
Study measures biomarkers of inflammation in Crohn's disease
Biomarkers : 23 August, 2011
Quanterix, which is company offering a new generation of molecular diagnostic tests based on the company's revolutionary Single Molecule Array (SiMoA) technology, releases results of a pilot study to measure biomarkers of inflammation from patients with Crohn's disease.
Clinical assay for Procalcitonin showcases at Critical Care Conference 2011
Biomarkers : 11 January, 2011
Thermo Fisher Scientific plans to showcase its clinical assay for Procalcitonin (PCT), which aids in the risk assessment of critically ill patients with sepsis, at the Society of Critical Care Medicine (SCCM) 40th Critical Care Conference 2011.
Roche Diagnostics and ACC develop biomarkers clinical resource Web portal
Biomarkers : 21 May, 2010
Roche Diagnostics and the American College of Cardiology (ACC) begin a collaboration to develop a peer-reviewed biomarkers clinical resource Web portal.
Thermo Fisher Scientific seeks to improve biomarkers for clinical proteomics
Biomarkers : 23 April, 2010
Thermo Fisher Scientific and Professor Bruno Domon, director of the new Luxembourg Clinical Proteomics unit (LCP), are collaborating to develop workflows that overcome current bottlenecks in biomarker discovery and assay development for clinical proteomics research.
Agendia prepares to take part in the I-SPY 2 Trial for breast cancer
Biomarkers : 22 March, 2010
Agendia is to participate in the I-SPY 2 Trial for breast cancer, set to launch at the first of nearly twenty research sites.
Qiagen acquires licence for PI3K biomarker to develop real-time-PCR
Biomarkers : 10 February, 2010
Qiagen's wholly owned subsidiary DxS acquires the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.
Abbott and BG Medicine develop biomarker for heart failure test
Biomarkers : 17 November, 2009
Abbott and BG Medicine agrees a development and commercialization deal for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure.
New Complex Proeomics Standard
Biomarkers : 30 September, 2009
Agilent is assisting protein biomarker discovery with a complex proteomics standard introduced at the HUPO congress
EEG-based biomarker trial results
Biomarkers : 14 September, 2009
Aspect Medical demonstrates the use for antidepressant treatment effectiveness of biomarkers
DiaGenic signs MCI biomarkers deal with Merz Pharmaceuticals
Biomarkers : 25 June, 2009
DiaGenic signs an option agreement with Merz Pharmaceuticals, a developer of drugs for treatment of illnesses in neurology and psychiatry, to gain access to biomarkers for Mild Cognitive Impairment (MCI), increasingly considered a transitional stage to Alzheimer's disease.
RBM releases quantitative immunoassays for identifying new protein biomarker patterns
Biomarkers : 18 June, 2009
Rules-Based Medicine (RBM), the world's leading multiplexed biomarker testing laboratory, releases a collection of quantitative immunoassays for use in advancing safety, efficacy and efficiency in drug and diagnostic development.
New gene expression biomarkers offer improved bowel cancer screening
Biomarkers : 05 June, 2009
Australian researchers develop gene expression biomarkers which can accurately discriminate pre-cancerous and cancerous colorectal growths from non-cancerous controls.
Qiagen launches molecular test kit for prenatal diagnostics
Biomarkers : 26 May, 2009
Qiagen is launching a novel product for extraction of free circulating fragments of tumour- and foetal-derived nucleic acids as well as viral nucleic acids in human blood.
Moffitt Cancer Center agrees phospholipid biomarkers license deal with Frantz BioMarkers
Biomarkers : 18 May, 2009
Moffitt Cancer Center and Frantz BioMarkers sign a license agreement on phospholipid biomarkers of ovarian cancer.
Sirius Genomics partners Vanderbilt University to study acute lung injury biomarkers
Biomarkers : 08 May, 2009
Sirius Genomics signs a collaborative agreement with Vanderbilt University to study patients enrolled in Vanderbilt's Validating Acute Lung Injury biomarkers for Diagnosis (VALID) study.
deCODE partners Celera to offer risk markers for cardiovascular and metabolic diseases
Biomarkers : 24 April, 2009
deCODE genetics and Celera are collaborating under an agreement which sees deCODE granting Celera non-exclusive worldwide licenses to deCODE's genetic markers for increased risk of major cardiovascular and metabolic diseases, including heart attack, stroke, atrial fibrillation (AF) and type 2 diabetes (T2D).
Improved assay sensitivity helps University of Middlesex 'scancer biomarker research
Biomarkers : 27 March, 2009
The University of Middlesex, (Hendon, UK) is finding that the Thermo Scientific Verso cDNA Synthesis Kit and Thermo Scientific ABsolute Blue QPCR Master Mix are helping in its cancer biomarker research projects, offering improved assay sensitivity and ease of use.
Biomarker study indicates OvaCalc algorithm helps to estimate malignancy risk
Biomarkers : 11 February, 2009
Vermillion has presented data from its prospective OVA1 clinical trial at the Society of Gynecologic Oncologists' (SGO) 40th Annual Meeting on Women's Cancer in San Antonio, Texas, USA.
Power3 Medical Products finalises neurodegenerative biomarkers licence deal
Biomarkers : 04 February, 2009
Transgenomic and Power3 Medical Products have finalised a definitive collaboration and exclusive license agreement for the rights to Power3 Medical's neurodegenerative biomarkers.
RBM launches Human Kidney Multi-Analyte Profile biomarker testing service
Biomarkers : 16 January, 2009
Rules-Based Medicine (RBM), the world's leading multiplexed biomarker testing laboratory, has launched its Human Kidney Multi-Analyte Profile (MAP), a cost-effective biomarker testing service designed to aid pharmaceutical and biotechnology companies in their efforts to improve drug development through better understanding of drug toxicity.
ExonHit unveils new SpliceArray to speed therapeutic target discovery
Biomarkers : 01 December, 2008
ExonHit Therapeutics has introduced its new SpliceArray for use in studying mouse models of human disease.
NIAID awards Caprion a $12.9 million infectious disease biomarkers contract
Biomarkers : 07 October, 2008
Caprion Proteomics has been awarded a $12.9 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the US National Institutes of Health, to carry out Biodefense research in the area of infectious disease biomarkers.
New study shows microRNA biomarkers in blood serum indicate cancers
Biomarkers : 08 September, 2008
The results of a study conducted by Rosetta Genomics’ scientists describes the identification of microRNA biomarkers in blood serum and has been published online in the peer-reviewed journal PLOS One.
Researchers develop new diagnostic marker for early detection of acute kidney injury
Biomarkers : 30 July, 2008
Researchers have developed a new diagnostic marker, called urine NGAL, for early detection of acute kidney injury (AKI) in hospitalised patients can distinguish AKI from other forms of kidney dysfunction and prevent kidney failure.
Rosetta Genomics and Rabin Medical Center collaborate to develop microRNA-based diagnostics
Biomarkers : 26 June, 2008
Rosetta Genomics is collaborating with the Rabin Medical Center in Israel to develop microRNA-based diagnostics in the fields of oncology, gynaecology, and obstetrics.
FASgen Diagnostics and Tetracore to collaborate to develop cancer biomarker tests
Biomarkers : 30 May, 2008
FASgen Diagnostics and Tetracore have announced that they have entered into a collaboration to produce cGMP ELISA and IHC tests for cancer biomarkers using FASgen's proprietary antibodies.
Petnet’s Nottingham site is granted FDG biomarker manufacturing licence
Biomarkers : 12 May, 2008
Petnet Solutions has been granted a full Marketing Authorisation and Manufacturers/Importers Licence (MIA) for the production and distribution of its ′MetaTrace’ fludeoxyglucose (FDG) biomarker from its Nottingham City Hospital site.
CMM and Qiagen collaborate to discover molecular biomarkers for breast cancer
Biomarkers : 18 February, 2008
The Center for Molecular Medicine (CMM) is to collaborate with its affiliates and Qiagen to support research focused on discovering molecular biomarkers capable of helping diagnose breast cancer and other women's health issues.
BG Medicine acquires exclusive commercial rights to vascular plaque rupture biomarker
Biomarkers : 07 February, 2008
BG Medicine and ACS Biomarker have entered into an agreement in which BG Medicine has obtained rights to develop and commercialise a novel clinical diagnostic test for acute atherothrombosis based on a biomarker discovered by the Cardiovascular Research Institute Maastricht (CARIM).
Rubicon collaborates with OncoMethylome to identify cancer biomarkers
Biomarkers : 23 January, 2008
Rubicon Genomics has entered into a collaboration agreement with OncoMethylome Sciences for the identification of biomarkers for early detection of cancer.
BG Medicine launches BioImage Study to achieve early identification of high risk heart attack or stroke victims
Biomarkers : 20 December, 2007
BG Medicine, on behalf of the HRP Initiative, has launched the BioImage Study, designed to discover new blood tests and to optimise non-invasive imaging of atherosclerosis in order to identify and characterise individuals that are at high-risk for coronary heart disease or stroke.
Rosetta and Columbia University Medical Center work to develop diagnostic tests
Biomarkers : 14 December, 2007
Rosetta Genomics and Columbia University Medical Center are to collaborate to develop microRNA-based diagnostic tests, early detection as well as prognosis, for three types of Non-Hodgkin Lymphoma (NHL).
Rosetta licenses MGB Probe technology to support new PCR Diagnostic Assays
Biomarkers : 12 December, 2007
Rosetta Genomics has selected Nanogen’s MGB Probe technology as the platform for its new range of microRNA-based diagnostic products, the first of which are expected to launch in 2008.
Xceed Molecular signs up Center for Molecular Medicine to new Strategic Collaborator programme
Biomarkers : 29 November, 2007
Xceed Molecular has launched its Strategic Collaborator programme and signed its first member, the Center for Molecular Medicine (CMM), of Grand Rapids, Michigan, USA.
Dutch researchers identify microRNA molecular markers linked with testicular cancer
Biomarkers : 19 October, 2007
Researchers at the Erasmus MC-University Medical Center in Rotterdam, The Netherlands and Applied Biosystems have identified and analysed a set of specific microRNA molecular markers that are involved in the development of testicular tumours.
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo